Do I need to change my diet and exercise if I am on GLP-1
Heart Support: a Nuanced Conversation, Not a Shortcut Heart-related interest in L-carnitine has a long history, and research continues to examine how nutrients and diet formulation relate to cardiac health
Dosing Protocol Key Considerations for Liraglutide Adolescent approval: Saxenda is FDA-approved for adolescents aged 12 and older with obesity (BMI at or above the 95th percentile for age and sex), making it the incretin-based obesity treatment with the broadest pediatric indication Established safety profile: With more than a decade of post-marketing surveillance data, liraglutide has the longest safety track record among GLP-1 agonists used for weight management Daily dosing: The daily injection requirement is a disadvantage for some patients but an advantage for those who prefer more consistent drug levels and find weekly injections anxiety-provoking Efficacy: Mean weight loss of 5-8% of body weight, lower than semaglutide (15-17%) or tirzepatide (20-26%), which positions liraglutide as a second-line option in this drug class for most adult patients Tirzepatide: Dual GIP/GLP-1 Agonism Tirzepatide (Zepbound for obesity
10 This is largely credited to the medical support (both in-person and digital), and nutrition and behaviour coaching that are key elements of the programme
2021;doi:10.1093/ehjcvp/pvab008 Lomuscio A, Belletti S, Battezzati PM, Lombardi F
